Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Repurposing the anti-parasitic agent pentamidine for cancer therapy; a novel approach with promising anti-tumor properties

Fig. 2

Redirecting PTM administration from conventional applications to novel ones. Recent findings suggest that not only can PTM act as an anti-microbial agent but also exhibit other pharmacological characteristics that may be harnessed in other therapy fields such as the treatment of Alzheimer’s disease, diabetes, muscular disorders, COVID-19, and cancer

Back to article page